Structure and biological properties of lentztrehalose: a novel trehalose analog

J Antibiot (Tokyo). 2014 Apr;67(4):319-22. doi: 10.1038/ja.2013.143. Epub 2014 Jan 22.

Abstract

A new trehalose analog, lentztrehalose [4-O-(2,3-dihydroxy-3-methylbutyl)trehalose], was isolated from an actinomycete Lentzea sp. Lentztrehalose is only weakly hydrolyzed by the trehalose-hydrolyzing enzyme, trehalase, so can be regarded as an enzyme-stable analog of trehalose. Although lentztrehalose does not show apparent toxicity to mammalian cells and microbes, it has antitumor activity in mice bearing S-180 sarcoma and Ehrlich carcinoma cells. In ovariectomized mice, lentztrehalose displayed a bone reinforcement effect in the femur that was superior to trehalose and induced non-morbid suppression of weight gain comparable with trehalose. These results indicate that enzyme-stable analogs of trehalose, such as lentztrehalose, may be more beneficial for human health and thus have potential as substitutes for trehalose as a sweetener.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinobacteria / growth & development
  • Actinobacteria / metabolism*
  • Actinobacteria / ultrastructure
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / therapeutic use*
  • Bone Density Conservation Agents / chemistry
  • Bone Density Conservation Agents / isolation & purification
  • Bone Density Conservation Agents / metabolism
  • Bone Density Conservation Agents / therapeutic use*
  • Carcinoma, Ehrlich Tumor / drug therapy*
  • Carcinoma, Ehrlich Tumor / pathology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Female
  • Humans
  • Mice
  • Mice, Inbred ICR
  • Molecular Structure
  • Non-Nutritive Sweeteners / chemistry
  • Non-Nutritive Sweeteners / isolation & purification
  • Non-Nutritive Sweeteners / metabolism
  • Non-Nutritive Sweeteners / therapeutic use
  • Osteoporosis, Postmenopausal / prevention & control*
  • Sarcoma 180 / drug therapy*
  • Sarcoma 180 / pathology
  • Substrate Specificity
  • Survival Analysis
  • Trehalase / metabolism
  • Trehalose / analogs & derivatives*
  • Trehalose / chemistry
  • Trehalose / isolation & purification
  • Trehalose / metabolism
  • Trehalose / therapeutic use
  • Tumor Burden / drug effects
  • Weight Gain / drug effects

Substances

  • 4-O-(2,3-dihydroxy-3-methylbutyl)trehalose
  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Non-Nutritive Sweeteners
  • Trehalose
  • Trehalase